SCHEMBL7732691

SCHEMBL7732691

O[C@@H]1[C@H](O)[C@@H](COC(F)(F)F)O[C@H]1n1cnc2c(Cl)ncnc21

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TYMP P19971 4/20 0.76
ADORA1 P30542 5/20 0.55
P2RY1 P47900 4/20 0.53
SMN1; SMN2 Q16637 3/20 0.53
P2RY2 P41231 3/20 0.53
SRC P12931 2/20 0.53
DNPH1 O43598 1/20 0.53
PRKAB2 O43741 1/20 0.53
TRPM2 O94759 1/20 0.53
LDHA P00338 1/20 0.53
ADRB2 P07550 1/20 0.53
FBP1 P09467 1/20 0.53
PRKAG1 P54619 1/20 0.53
PRKAA2 P54646 1/20 0.53
PDE4D Q08499 1/20 0.53
KCNH2 Q12809 1/20 0.53
PRKAA1 Q13131 1/20 0.53
PDE3A Q14432 1/20 0.53
TAS1R3 Q7RTX0 1/20 0.53
TAS1R1 Q7RTX1 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7734176 0.87 TYMP (0.65) TYMPADORA1P2RY1SMN1; SMN2P2RY2
SCHEMBL16554813 0.87 ADORA1 (0.71) ADORA1P2RY1SMN1; SMN2P2RY2SRC
SCHEMBL7067735 0.87 ADORA1 (0.71) ADORA1P2RY1SMN1; SMN2P2RY2SRC
SCHEMBL7067739 0.87 ADORA1 (0.71) ADORA1P2RY1SMN1; SMN2P2RY2SRC
SCHEMBL5270000 0.87 TYMP (1.00) TYMPADORA1DNPH1SLC29A1STAT6
SCHEMBL1796310 0.87 TYMP (1.00) TYMPADORA1DNPH1SLC29A1STAT6
SCHEMBL22458597 0.87 TYMP (1.00) TYMPADORA1DNPH1SLC29A1STAT6
SCHEMBL8207328 0.85 TYMP (0.68) TYMPADORA1P2RY1SMN1; SMN2P2RY2
SCHEMBL7197169 0.85 TYMP (0.68) TYMPADORA1P2RY1SMN1; SMN2P2RY2
SCHEMBL6560740 0.85 TYMP (0.68) TYMPADORA1P2RY1SMN1; SMN2P2RY2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6407076-B1 ANTIISCHEMIC, ANTILIPOLYTIC, ANTICONVULSANT AND HYPOTENSIVE AGENTS; CARDIOVASCULAR AND NERVOUS SYSTEM DISORDERS; ATHEROSCLEROSIS SMITHKLINE BEECHAM CORPORATION 2002-06-18 US disclosed
EP-1027363-A2 ADENOSINE A1-RECEPTOR AGONISTS GLAXO GROUP LIMITED (GB) 2000-08-16 EP disclosed
WO-1999024450-A2 ADENSINE A1 RECEPTOR AGONISTS GLAXO GROUP LIMITED (GB) 1999-05-20 WO disclosed